| 30024930.30 |
Viral vectors for CAR-T cell therapy production |
kilogram/piece |
20% |
AB |
P/V/Q/W |
-- |
| 30024930.90 |
Other bacteria and viruses |
kilogram/piece |
20% |
AB |
P/V/Q/W |
Compare-30024930.30 |
| 30024990.10 |
Botrytis cinerea, Penicillium purpureum, Trichoderma harzianum, and Fusarium oligosporum |
kilogram/- |
20% |
ABS |
P/V/Q/W |
Compare-30024930.90 |
| 30024990.20 |
Other dual-use items control toxins, cultured microorganisms (excluding yeast), and similar products |
kilogram/- |
20% |
3AB |
P/V/Q/W |
Compare-30024990.10 |
| 30024990.90 |
Other toxins, cultured microorganisms (excluding yeast), and similar products |
kilogram/- |
20% |
AB |
P/V/Q/W |
Compare-30024990.20 |
| 30025100.10 |
Cell therapy products included in the list of anti-cancer drugs |
kilogram/- |
20% |
AB |
P/V/Q/W |
Compare-30024990.90 |
| 30025100.90 |
Other cell therapy products |
kilogram/- |
20% |
AB |
P/V/Q/W |
Compare-30025100.10 |
| 30025900.00 |
Other cell cultures, whether modified or not |
kilogram/- |
20% |
AB |
P/V/Q/W |
Compare-30025100.90 |
| 30029040.10 |
Genetics materials and gene-modified organisms under control of sensitive items |
kilogram/- |
20% |
3AB |
P/V/Q/W |
Compare-30025900.00 |
| 30029040.90 |
Other genetics materials and gene-modified organisms |
kilogram/- |
20% |
AB |
P/V/Q/W |
Compare-30029040.10 |
| 30029090.01 |
Human blood |
kilogram/- |
20 |
ABV |
V/W |
Compare-30029040.90 |
| 30029090.10 |
Blood products from endangered animals for therapeutic, preventive or diagnostic purposes |
kilogram/- |
20 |
ABQFE |
P/Q |
Compare-30029090.01 |
| 30029090.90 |
Other animal blood products used for treatment, prevention or diagnosis |
kilogram/- |
20 |
ABQ |
P/Q |
Compare-30029090.10 |
htshub©